Advertisement
    Search all headlines
    Yesterday
    In the last month
    Lilly acquires inflammatory firm Ventyx Biosciences for $1.2bn deal European Pharmaceutical Review14:07 8-Jan-26
    Eli Lilly acquires inflammatory specialist Ventyx for $1.2bn Pharmaceutical Technology11:32 8-Jan-26
    Lilly buying Ventyx for $1.2B BioWorld22:23 7-Jan-26
    Is Lilly negotiating to buy Ventyx Bio? pharmaphorum13:05 7-Jan-26
    view more headlines
    5 Feb 22:26

    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.